Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders
Clinical Therapeutics June 1, 2026 Anna Luiza Guimarães, Fernando R. Beserra, Lucas Cruz et al.
PURPOSE: The interest in psychedelics for health-related purposes has grown significantly over the past decade. However, there is an insufficient representation of stakeholders (eg, Indigenous groups, activists, policymakers) in discussions about research and regulation. Many psychedelics originate from traditional practices historically developed in low- and middle-income countries, but these...